FORE Biotherapeutics vs Pangea Biomed
FORE Biotherapeutics vs Pangea Biomed, compared side by side on 21 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: FORE Biotherapeutics is on 56/100 and Pangea Biomed on 55/100.
Where each one leads
FORE Biotherapeutics
- domain rating: 33/100 against 14/100
- headcount: 56 against 16
- headcount growth: +8.2% against +2.0%
- funding raised: $232M against $12.0M
- LinkedIn following: 4,584 against 1,127
Pangea Biomed
Leads on none of the measures we hold for both companies.
At a glance
| Measure | FORE Biotherapeutics | Pangea Biomed |
|---|---|---|
| What it is | Precision oncology company developing cancer therapies guided by proprietary functional genomics. | Biotech company using AI and deep RNA analysis to predict cancer treatment response. |
| Category | Healthcare, Drug Development, Genomics, Next Generation Sequencing | Healthcare, Oncology, Genomics, Biotech |
| Sells toBusiness model | B2B | B2B, B2C |
| Offering | Software | Software |
| Founded | 2011 | 2019 |
| Headquarters | Philadelphia, United States | Tel Aviv, Israel |
| Status | Active | Active |
Size, funding and growth
| Measure | FORE Biotherapeutics | Pangea Biomed |
|---|---|---|
| Employees | 56 | 16 |
| Headcount growthLast 12 months | +8.2% | +2.0% |
| Total funding | $232M | $12.0M |
| Latest round | Series D-2 Extension | Seed |
| Valuation | $75.0M | Not published |
| LinkedIn followers | 4,584 | 1,127 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | FORE Biotherapeutics | Pangea Biomed |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 56/100 | 55/100 |
| Traction | 58/100 | 48/100 |
| Team | 70/100 | 70/100 |
| Search visibility | 38/100 | 28/100 |
| Quality | 55/100 | 58/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (37/100) | F (39/100) |
| Domain ratingLink authority, 0-100 | 33/100 | 14/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | FORE Biotherapeutics | Pangea Biomed |
|---|---|---|
| CDN | Not detected | Cloudflare |
| CMS | WordPress | WordPress |
| Frameworks | Jquery | Jquery, Bootstrap |
FORE Biotherapeutics vs Pangea Biomed: common questions
Which is better, FORE Biotherapeutics or Pangea Biomed?
On our 0-100 score FORE Biotherapeutics rates higher (56/100 against 55/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 21 data points above: read the rows that match what you are buying for.
How do FORE Biotherapeutics and Pangea Biomed compare on the numbers?
FORE Biotherapeutics leads on domain rating (33/100 against 14/100), headcount (56 against 16), headcount growth (+8.2% against +2.0%), funding raised ($232M against $12.0M), LinkedIn following (4,584 against 1,127).
Read the full FORE Biotherapeutics review and pricing or the Pangea Biomed review and pricing. You can also browse other FORE Biotherapeutics alternatives we track.